$CCXI #Stocks #StockMarket #Chemocentryx reported Q4 EPS on https://t.co/savSNTKlN1: CCXI reported disastrous Q4, where Sales faded by -61.511 % to $20.094 MM and loss per share has widen to $-0.26, from the same quarter a year ago. https://t.co/C5Iv6b7CqN